Two pathogen reduction technologies—methylene blue plus light and shortwave ultraviolet light—effectively inactivate hepatitis C virus in blood products
Article first published online: 21 AUG 2012
© 2012 American Association of Blood Banks
Volume 53, Issue 5, pages 1010–1018, May 2013
How to Cite
Steinmann, E., Gravemann, U., Friesland, M., Doerrbecker, J., Müller, T. H., Pietschmann, T. and Seltsam, A. (2013), Two pathogen reduction technologies—methylene blue plus light and shortwave ultraviolet light—effectively inactivate hepatitis C virus in blood products. Transfusion, 53: 1010–1018. doi: 10.1111/j.1537-2995.2012.03858.x
- Issue published online: 9 MAY 2013
- Article first published online: 21 AUG 2012
- Received for publication March 5, 2012; revision received May 31, 2012, and accepted July 18, 2012.
Options for accessing this content:
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!